Free Trial

Iofina (IOF) Competitors

Iofina logo
GBX 23.11 -0.26 (-1.13%)
As of 11:36 AM Eastern

IOF vs. TET, SYNT, HAYD, WCH, ITX, DCTA, HDD, BIOM, ZED, and ESKN

Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Treatt (TET), Synthomer (SYNT), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), Biome Technologies (BIOM), Zenova Group (ZED), and Esken (ESKN). These companies are all part of the "specialty chemicals" industry.

Iofina vs. Its Competitors

Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Treatt has a net margin of 7.88% compared to Iofina's net margin of 6.98%. Treatt's return on equity of 8.09% beat Iofina's return on equity.

Company Net Margins Return on Equity Return on Assets
Treatt7.88% 8.09% 6.72%
Iofina 6.98%8.00%5.18%

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treatt£145.16M1.14£11.22M£0.181,526.99
Iofina£57.65M0.77£4.28M£0.03924.40

42.1% of Treatt shares are held by institutional investors. Comparatively, 0.5% of Iofina shares are held by institutional investors. 4.1% of Treatt shares are held by company insiders. Comparatively, 13.4% of Iofina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Treatt has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Iofina has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500.

In the previous week, Treatt had 2 more articles in the media than Iofina. MarketBeat recorded 2 mentions for Treatt and 0 mentions for Iofina. Treatt's average media sentiment score of 0.34 beat Iofina's score of 0.00 indicating that Treatt is being referred to more favorably in the media.

Company Overall Sentiment
Treatt Neutral
Iofina Neutral

Treatt presently has a consensus price target of GBX 256.67, indicating a potential downside of 8.35%. Iofina has a consensus price target of GBX 40, indicating a potential upside of 73.09%. Given Iofina's stronger consensus rating and higher possible upside, analysts plainly believe Iofina is more favorable than Treatt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treatt
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Treatt beats Iofina on 13 of the 16 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOF vs. The Competition

MetricIofinaSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£44.34M£7.44B£3.78B£2.60B
Dividend Yield2.88%3.47%5.05%5.29%
P/E Ratio924.40641.91158.534,449.24
Price / Sales0.7797.7223,129.8799,975.32
Price / Cash7.9619.2524.3627.90
Price / Book1.032.897.088.35
Net Income£4.28M£220.83M£149.07M£5.89B
7 Day Performance4.41%2.01%3.02%0.99%
1 Month Performance-8.29%1.53%12.62%6.24%
1 Year Performance20.05%-4.53%55.78%158.61%

Iofina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOF
Iofina
N/AGBX 23.11
-1.1%
GBX 40
+73.1%
+21.4%£44.34M£57.65M924.4095Gap Up
TET
Treatt
0.89 of 5 stars
GBX 267
-0.4%
GBX 256.67
-3.9%
-37.5%£157.41M£145.16M1,455.83350Dividend Increase
Gap Down
SYNT
Synthomer
2.6437 of 5 stars
GBX 73.24
+0.5%
GBX 142.50
+94.6%
-63.7%£119.73M£1.89B-143.334,200
HAYD
Haydale Graphene Industries
N/AGBX 0.55
+4.8%
N/AN/A£23.78M£3.61M-166.6767Gap Up
WCH
Wilmcote Holdings plc (WCH.L)
N/AN/AN/AN/A£20.13MN/A-5.003
ITX
Itaconix
1.3453 of 5 stars
GBX 115
+4.5%
GBX 325
+182.6%
-20.8%£15.51M£8.55M-833.3317
DCTA
Directa Plus
N/AGBX 10
-2.4%
N/A-17.4%£10.44M£7.17M-166.67187Gap Up
HDD
Hardide
N/AGBX 7.75
+5.1%
N/A+13.1%£6.11M£5.42M-1,937.5046Gap Down
BIOM
Biome Technologies
N/AGBX 9.38
+7.2%
N/A+58.3%£4.84M£5.75M-27.5927Gap Up
ZED
Zenova Group
N/AGBX 0.21
flat
N/AN/A£762K£100K-27.3311
ESKN
Esken
N/AN/AN/AN/A£714K£114.53M-0.88678Gap Down

Related Companies and Tools


This page (LON:IOF) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners